Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.Daniel Gossett, Ph.D. | PAR-20-140
Source: NIDDK Funding Opportunities - Category: Endocrinology Source Type: funding